Cargando…
Growth hormone receptor promotes breast cancer progression via the BRAF/MEK/ERK signaling pathway
Growth hormone receptor (GHR), a member of the class I cytokine receptor family, plays key roles in cancer progression. Recently, GHR has been reported to be associated with breast cancer development, but the molecular mechanism of GHR in this malignancy is not fully understood. To investigate this...
Autores principales: | Zhu, Xiaojue, Li, Yonghao, Xu, Guoxin, Fu, ChangQing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262926/ https://www.ncbi.nlm.nih.gov/pubmed/32069380 http://dx.doi.org/10.1002/2211-5463.12816 |
Ejemplares similares
-
BRAF/MEK inhibitors promote CD47 expression that is reversible by ERK inhibition in melanoma
por: Liu, Fen, et al.
Publicado: (2017) -
Pharmacological inhibition of USP7 promotes antitumor immunity and contributes to colon cancer therapy
por: Fu, Changqing, et al.
Publicado: (2019) -
Growth Inhibitory Signaling of the Raf/MEK/ERK Pathway
por: Wu, Pui-Kei, et al.
Publicado: (2020) -
RDM1 promotes neuroblastoma growth through the RAS–Raf–MEK–ERK pathway
por: Xie, Guojin, et al.
Publicado: (2019) -
MEK5/ERK5 Signaling Suppresses Estrogen Receptor Expression and Promotes Hormone-Independent Tumorigenesis
por: Antoon, James W., et al.
Publicado: (2013)